Medical Devices: Page 24
-
saengsuriya13 via Getty Images
Baxter considers sale of kidney care unit to PE firm: WSJ
Carlyle Group could reportedly pay more than $4 billion for Baxter’s Vantive business.
By Elise Reuter • July 8, 2024 -
Permission granted by Becton Dickinson
BD to close Ireland facility, putting 170 jobs at risk
A company spokesperson said the decision follows a recent review and reflects a push to improve operational efficiency.
By Nick Paul Taylor • July 8, 2024 -
Explore the Trendlineâž”
Sarah Silbiger via Getty Images
TrendlineMedical device safety in spotlight after high profile recalls
From Philips’ massive recall of respiratory devices to ongoing health risks with breast implants, medical devices tied to patient harm have put a focus on product safety.
By MedTech Dive staff -
Mario Tama / Staff via Getty Images
Masimo employees rally around CEO Kiani as proxy fight looms
Hundreds of healthcare engineers have joined managers to support founder and CEO Joe Kiani as he battles an activist shareholder for control of the company.
By Susan Kelly • July 3, 2024 -
Zorica Nastasic via Getty Images
Alcon buys Belkin Vision for $81M upfront
Alcon will gain access to a laser treatment for glaucoma that it plans to sell in the U.S. by the end of the year.
By Nick Paul Taylor • July 3, 2024 -
Jajah-sireenut via Getty Images
Merit Medical pays Endogastric $105M for acid reflux treatment
Merit expects the device to add around $30 million in annual sales.
By Nick Paul Taylor • July 2, 2024 -
Retrieved from Cardinal Health on July 02, 2024
FDA continues crackdown on plastic syringes made in China
The agency has issued import bans for four manufacturers, and multiple companies have recalled affected syringes. Check out MedTech Dive’s roundup of the news.
By Elise Reuter • July 2, 2024 -
Sarah Silbiger via Getty Images
FDA to expand total product life cycle program
Officials plan to start accepting radiological and ophthalmic medical devices into the program, designed to accelerate medtech innovation, in October.
By Nick Paul Taylor • July 2, 2024 -
Courtesy of BusinessWire/Masimo
Masimo COO says he’ll resign if CEO Kiani is forced out
Activist investor Politan Capital Management is attempting to remove longtime Masimo leader Joe Kiani, claiming the company lacks independent oversight.
By Susan Kelly • July 1, 2024 -
Mario Tama/Getty via Getty Images
Medtech M&A may pick up after mixed start to 2024: analysts
The annual number of medtech acquisitions is on course to slump to its lowest level since 2017, according to Needham.
By Nick Paul Taylor • July 1, 2024 -
Patrik Stollarz / Staff via Getty Images
FDA walks back injury, death reports on recent Philips BiPAP recall
The agency now says 10 injuries and seven deaths are associated with the problem. The updated numbers match figures shared by Philips and are significantly below the original report.
By Elise Reuter • Updated July 11, 2024 -
Courtesy of Dexcom, Nick Jonas Super Bowl kit
Dexcom to lay off 535 employees in California
A company spokesperson said Dexcom is centralizing its U.S. manufacturing operations in Arizona and repurposing its San Diego facility.
By Ricky Zipp • June 27, 2024 -
Courtesy of HP
Medtronic CFO Karen Parkhill leaving for HP
Truist analysts wrote that “there could be some investor angst until a permanent successor is announced.”
By Nick Paul Taylor • June 27, 2024 -
Peter Macdiarmid via Getty Images
Zimvie mulls sale after takeover approaches: Bloomberg
Zimvie is reportedly working with an adviser to assess its options after strategic investors and industry players showed interest in a deal.
By Nick Paul Taylor • June 26, 2024 -
Courtesy of Dexcom
Abbott and Dexcom are launching the first over-the-counter CGMs. Here are 7 questions on the new tech.
Experts expect the release of new over-the-counter glucose monitors in the U.S. to fuel more widespread use of the devices.
By Elise Reuter • June 26, 2024 -
mathisworks via Getty Images
Beyond Air cut more than 20% of employees
BTIG analysts said the company’s near-term cash needs, “disappointing sales results and lack of progress on profitability metrics” are concerning.
By Nick Paul Taylor • June 26, 2024 -
Permission granted by Embecta
Embecta touts its insulin patch pump at ADA
Embecta said its device, with a larger insulin reservoir, addresses an unmet need for people with Type 2 diabetes.
By Elise Reuter • June 25, 2024 -
Retrieved from Ascensia Diabetes Care on June 25, 2024
Senseonics tips 365-day CGM to double 2025 sales
Senseonics is in talks with insulin pump manufacturers about integrating its implantable Eversense continuous glucose monitor with their devices.
By Nick Paul Taylor • June 25, 2024 -
Courtesy of Insulet Corp.
Insulet seeks label expansion of Omnipod 5 for Type 2 diabetes
At the American Diabetes Association meeting, Insulet shared study results showing improvements in blood glucose and quality of life.
By Elise Reuter • June 24, 2024 -
Sarah Silbiger via Getty Images
Cardinal Health recalls procedure kits over plastic syringes made in China
Cardinal listed more than 500 catalog numbers in its recall notice and told customers to remove and discard the syringes.
By Nick Paul Taylor • June 24, 2024 -
Courtesy of Orthofix
Orthofix’s president of global orthopedics resigns
Kimberley Elting will end her eight-year stint at the company in July, continuing Orthofix's recent trend of executive turnover.
By Nick Paul Taylor • June 24, 2024 -
Patrik Stollarz / Staff via Getty Images
Philips Respironics to end manufacturing at two Pennsylvania plants: report
Philips said it would transition operations from the two sites to a third-party manufacturer. The plan will cut 300 jobs, according to the Pittsburgh Post-Gazette.
By Elise Reuter • June 21, 2024 -
Courtesy of Tandem Diabetes Care
Tandem names Jean-Claude Kyrillos as chief operating officer
The appointment gives Kyrillos a leading role in work to expand the insulin delivery company’s global operations and achieve profitable growth.
By Nick Paul Taylor • June 21, 2024 -
Mario Tama via Getty Images
J&J creates open digital platform for surgical applications
J&J at first will focus on surgical video, telepresence and planning and limit access to select hospitals. It plans to make the platform more widely available in 2025.
By Nick Paul Taylor • June 21, 2024 -
Sasirin Pamai via Getty Images
Globus Medical gets FDA nod for ortho robot
With the clearance, Globus could gain share in the roughly $15 billion market for reconstructive orthopedic surgery, RBC Capital Markets analyst Shagun Singh said.
By Elise Reuter • June 20, 2024 -
Retrieved from Dermtech on June 20, 2024
Dermtech files for Chapter 11, lays off 20% of staff
The diagnostic test maker will continue to hunt for a buyer for its skin cancer detection patch.
By Nick Paul Taylor • June 20, 2024
Previous
